4//SEC Filing
Vogt Frederick G 4
Accession 0001104659-25-021872
CIK 0001425205other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 8:06 PM ET
Size
6.2 KB
Accession
0001104659-25-021872
Insider Transaction Report
Form 4
Vogt Frederick G
DirectorInterim CEO & General Counsel
Transactions
- Award
Restricted Stock Units
2025-03-05+187,500→ 187,500 total→ Common stock (187,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001719678
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 8:06 PM ET
- Size
- 6.2 KB